Andrew Pelling — SPARQNOW

At-a-Glance

Venture Partner at Pamir Ventures since 2025.
Co-Founder and Chief Scientific Officer of Spiderwort Inc. since 2015, commercializing plant-based biomaterials for medical use.
Pioneered research in plant-derived biomaterials for tissue engineering, founding the 'Pelling Lab for Augmented Biology' at the University of Ottawa.
Serves as an Entrepreneur in Residence at Temerty Faculty of Medicine, University of Toronto since 2022.
Holds a PhD in Physical Chemistry from UCLA (2005) and a BSc from the University of Toronto (2001).
Recognized as a Fellow of the Royal Society of Biology, a member of the College of the Royal Society of Canada, and a TED Senior Fellow.

Biography

Andrew Pelling is a scientist and seasoned entrepreneur known for his ability to translate fundamental scientific discoveries into real-world innovations. He has pioneered research advances in the life sciences and co-founded multiple technology, biotechnology, and healthcare startups. Currently, he serves as a Venture Partner at Pamir Ventures, leveraging his expertise in corporate growth, strategic investments, and executive leadership.